10
Participants
Start Date
September 30, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2026
Methylene Blue
"Subjects will be initially treated with an initial dose of 200mg/day for 8 weeks at which point the investigators will assess the effect of the treatment.~Those patients that obtain a complete response will continue their treatment up to a total of 24 weeks with the same dose. Those who do not reach a complete response will be exposed to the next higher dose of 400mg/day for the following 8 weeks and the investigators will then again assess the effect of the treatment.~Those patients that obtain a complete response will continue their treatment up to a total of 24 weeks with the same dose. Those who do not reach a complete response will be exposed to the next higher dose of 600mg/day for the following 8 weeks and the investigators will then assess the effect of the treatment."
RECRUITING
Epatocentro Ticino, Lugano
Fondazione Epatocentro Ticino
OTHER